Literature DB >> 9368676

Acute, nongenomic actions of the neuroactive gonadal steroid, 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP), on FSH release in perifused rat anterior pituitary cells.

C A Beck1, M Wolfe, L D Murphy, J P Wiebe.   

Abstract

We have previously shown that the gonadal and neurosteroid, 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP), can selectively suppress gonadotrophin-releasing hormone (GnRH) induced follicle-stimulating hormone (FSH) release from static cultures of anterior pituitary cells during a 4-h incubation period. The actions appeared to be at the level of the gonadotroph membrane and the cell signaling pathway involving Ca2+ and protein kinase C (PKC). In order to investigate further if the effects of 3 alpha HP on FSH release are generated by nongenomic mechanisms, we monitored the short-term effects of 3 alpha HP using dispersed anterior pituitary cells in a low dead-volume perifusion system with short (< or = 5 min) exposures to the steroid. Pulses of GnRH (10(-8) or 10(-7) M) lasting 2-5 min resulted in marked peaks of FSH release, and the variation in FSH amounts released from the cells in a particular column were minimal if the interval between successive GnRH pulses was at least 3-4 h. A 5-min pulse of 3 alpha HP (10(-9) M) administered simultaneously with the GnRH pulse suppressed GnRH-induced FSH release. On the other hand, similar treatment with the stereoisomer 3 beta-hydroxy-4-pregnen-20-one (3 beta HP), had no effect, but progesterone and estradiol pulses augmented the GnRH-induced FSH release. Pretreatment of cells with a 5-min pulse of 3 alpha HP, at 120, 60, or 30 min prior to a GnRH pulse suppressed the GnRH-induced FSH release. The suppression of GnRH-induced FSH release by 3 alpha HP was only partial if the start of the 3 alpha HP pulse occurred 0.5 or 1.0 min after the start of the GnRH pulse, and no suppression occurred if the start of the 3 alpha HP pulse was delayed by 2-5 min. The FSH release elicited by 5-min pulses of the Ca2+ ionophore A23187, the Ca2+ agonist BAY K8644, the PKC activator phorbol 12-myristate 13-acetate (PMA), or phospholipase C (PLC) was suppressed by simultaneous pulses of 3 alpha HP. The suppression of FSH release by 3 alpha HP appeared to be stereospecific, since no suppression was observed with 5 alpha-pregnane-3,20-dione (5 alpha P) or 3 alpha-hydroxy-5 alpha-pregnan-20-one (5 alpha P3 alpha). In separate experiments, cells were treated with pulses of BSA conjugates of 3 alpha HP, 3 beta HP, or progesterone; the 3 alpha HP-BSA, but not the 3 beta HP-BSA or the progesterone-BSA, suppressed the GnRH-induced release of FSH. The results of this study provide the first evidence that 3 alpha HP exerts immediate (nongenomic) and direct effects on GnRH-induced FSH release by interacting at the level of the pituitary gonadotroph membrane and the phosphoinositol cell signaling cascade involving Ca2+.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368676     DOI: 10.1007/BF02820496

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  45 in total

1.  A progesterone metabolite enhances the activity of the GABAA receptor complex at the pituitary level.

Authors:  M Vincens; C Shu; M Moguilewsky; D Philibert
Journal:  Eur J Pharmacol       Date:  1989-09-01       Impact factor: 4.432

Review 2.  Nongenomic aldosterone effects: the cell membrane as a specific target of mineralocorticoid action.

Authors:  M Wehling
Journal:  Steroids       Date:  1995-01       Impact factor: 2.668

3.  Progesterone modulation of gonadotropin secretion by dispersed rat pituitary cells in culture. III. A23187, cAMP, phorbol ester and DiC8-stimulated luteinizing hormone release.

Authors:  L C Krey; F Kamel
Journal:  Mol Cell Endocrinol       Date:  1990-03-26       Impact factor: 4.102

4.  Nongenomic steroid action: independent targeting of a plasma membrane calcium channel and a tyrosine kinase.

Authors:  C Mendoza; A Soler; J Tesarik
Journal:  Biochem Biophys Res Commun       Date:  1995-05-16       Impact factor: 3.575

5.  Activin modulates the intracellular signaling system activated by gonadotropin-releasing hormone: dual effect on calcium messenger system and protein kinase-C pathway.

Authors:  T Katayama; P M Conn
Journal:  Endocrinology       Date:  1994-01       Impact factor: 4.736

6.  Biphasic effects of estrogen on gonadotropin-releasing hormone-induced luteinizing hormone release in monolayer cultures of rat and monkey pituitary cells.

Authors:  L S Frawley; J D Neill
Journal:  Endocrinology       Date:  1984-02       Impact factor: 4.736

7.  Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor.

Authors:  P G Mermelstein; J B Becker; D J Surmeier
Journal:  J Neurosci       Date:  1996-01-15       Impact factor: 6.167

8.  Diacylglycerols release LH: structure-activity relations reveal a role for protein kinase C.

Authors:  P M Conn; B R Ganong; J Ebeling; D Staley; J E Neidel; R M Bell
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

9.  Interactions between 17 beta-estradiol and progesterone in the control of luteinizing hormone and follicle-stimulating hormone release in rat anterior pituitary cells in culture.

Authors:  J Drouin; F Labrie
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

10.  Ovarian steroids modulate endothelin-induced luteinizing hormone secretion from cultured rat pituitary cells.

Authors:  O Ortmann; D Wassmann; S S Stojilkovic; K J Catt; K D Schulz; G Emons
Journal:  Endocrinology       Date:  1993-12       Impact factor: 4.736

View more
  5 in total

1.  Fluoxetine-induced decrements in sexual responses of female rats and hamsters are reversed by 3α,5α-THP.

Authors:  Cheryl A Frye; Madeline E Rhodes
Journal:  J Sex Med       Date:  2010-04-20       Impact factor: 3.802

2.  Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.

Authors:  John P Wiebe; Guihua Zhang; Ian Welch; Heather-Anne T Cadieux-Pitre
Journal:  Breast Cancer Res       Date:  2013-05-11       Impact factor: 6.466

3.  Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma.

Authors:  Michael J Lewis; John P Wiebe; J Godfrey Heathcote
Journal:  BMC Cancer       Date:  2004-06-22       Impact factor: 4.430

4.  Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA).

Authors:  Yasuto Taguchi; Mirek Koslowski; Donald L Bodenner
Journal:  Nucl Recept       Date:  2004-08-19

5.  Allopregnanolone Alters the Gene Expression Profile of Human Glioblastoma Cells.

Authors:  Carmen J Zamora-Sánchez; Aylin Del Moral-Morales; Ana M Hernández-Vega; Valeria Hansberg-Pastor; Ivan Salido-Guadarrama; Mauricio Rodríguez-Dorantes; Ignacio Camacho-Arroyo
Journal:  Int J Mol Sci       Date:  2018-03-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.